Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Methoprene

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 587Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apex Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Trial
    Apex Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Trial

    29 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/apex-labs-meets-endpoints-in-first-of-its-kind-take-home-microdose-psilocybin-clinical-trial-301784863.html

    PR NEWSWIRE
    29 Mar 2023
    Share Share
    Apex Labs Doses First Patient in Take Home Psilocybin Clinical Trial
    Apex Labs Doses First Patient in Take Home Psilocybin Clinical Trial

    18 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/apex-labs-doses-first-patient-in-take-home-psilocybin-clinical-trial-301725090.html

    PR NEWSWIRE
    18 Jan 2023
    Share Share
    Apex Labs granted P 2a Trial Application approval by Health Canada
    Apex Labs granted P 2a Trial Application approval by Health Canada

    08 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/apex-labs-granted-phase-2a-clinical-trial-application-approval-by-health-canada-for-treatment-of-ptsd-in-veterans-301497853.html

    PRNEWSWIRE
    08 Mar 2022
    Share Share